These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 6344096)
1. The diabetic Zucker fatty rat. Clark JB; Palmer CJ; Shaw WN Proc Soc Exp Biol Med; 1983 May; 173(1):68-75. PubMed ID: 6344096 [TBL] [Abstract][Full Text] [Related]
2. Importance of imparied insulin-gene expression in occurrence of diabetes in obese rats. Koh G; Seino Y; Usami M; Matsuo T; Ikeda H; Yamamoto T; Tsuda K; Taminato T; Imura H Diabetes; 1990 Sep; 39(9):1050-6. PubMed ID: 1696558 [TBL] [Abstract][Full Text] [Related]
3. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555. Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762 [TBL] [Abstract][Full Text] [Related]
4. In vivo effects of insulin and bis(maltolato)oxovanadium (IV) on PKB activity in the skeletal muscle and liver of diabetic rats. Marzban L; Bhanot S; McNeill JH Mol Cell Biochem; 2001 Jul; 223(1-2):147-57. PubMed ID: 11681716 [TBL] [Abstract][Full Text] [Related]
5. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303 [TBL] [Abstract][Full Text] [Related]
6. Zucker and Wistar diabetic fatty rats show different response to adrenalectomy. Turkenkopf IJ; Kava RA; Feldweg A; Horowitz C; Greenwood MR; Johnson PR Am J Physiol; 1991 Oct; 261(4 Pt 2):R912-9. PubMed ID: 1928436 [TBL] [Abstract][Full Text] [Related]
7. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis. Colombo M; Kruhoeffer M; Gregersen S; Agger A; Jeppesen P; Oerntoft T; Hermansen K Metabolism; 2006 Jan; 55(1):43-52. PubMed ID: 16324918 [TBL] [Abstract][Full Text] [Related]
9. Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats. Blachère JC; Pérusse F; Bukowiecki LJ Metabolism; 2001 Aug; 50(8):945-51. PubMed ID: 11474483 [TBL] [Abstract][Full Text] [Related]
10. Effect of partial pancreatectomy on beta-cell mass in the remnant pancreas of Wistar fatty rats. Ogino T; Zhu M; Murakami T; Kuwajima M; Shima K J Med Invest; 1998 Aug; 45(1-4):103-10. PubMed ID: 9864970 [TBL] [Abstract][Full Text] [Related]
11. Feeding butter with elevated content of trans-10, cis-12 conjugated linoleic acid to obese-prone rats impairs glucose and insulin tolerance. Hamilton M; Hopkins LE; AlZahal O; MacDonald TL; Cervone DT; Wright DC; McBride BW; Dyck DJ Lipids Health Dis; 2015 Sep; 14():119. PubMed ID: 26415741 [TBL] [Abstract][Full Text] [Related]
12. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds. Wasan KM; Risovic V; Yuen VG; McNeill JH J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173 [TBL] [Abstract][Full Text] [Related]
13. Liver and muscle-fat type glucose transporter gene expression in obese and diabetic rats. Yamamoto T; Fukumoto H; Koh G; Yano H; Yasuda K; Masuda K; Ikeda H; Imura H; Seino Y Biochem Biophys Res Commun; 1991 Mar; 175(3):995-1002. PubMed ID: 2025268 [TBL] [Abstract][Full Text] [Related]
14. A new genetically obese-hyperglycemic rat (Wistar fatty). Ikeda H; Shino A; Matsuo T; Iwatsuka H; Suzuoki Z Diabetes; 1981 Dec; 30(12):1045-50. PubMed ID: 7030830 [TBL] [Abstract][Full Text] [Related]
15. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone. Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890 [TBL] [Abstract][Full Text] [Related]
16. Brain and liver insulin binding is decreased in Zucker rats carrying the 'fa' gene. Figlewicz DP; Dorsa DM; Stein LJ; Baskin DG; Paquette T; Greenwood MR; Woods SC; Porte D Endocrinology; 1985 Oct; 117(4):1537-43. PubMed ID: 3896761 [TBL] [Abstract][Full Text] [Related]
17. Impaired neural regulation of insulin secretion related to the leptin receptor gene mutation in Wistar fatty rats. Ohnuma H; Yamatani K; Daimon M; Igarashi M; Manaka H; Sasaki H; Kato T Physiol Behav; 2000 Sep; 70(5):527-32. PubMed ID: 11111007 [TBL] [Abstract][Full Text] [Related]
18. Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats. Harmon JS; Gleason CE; Tanaka Y; Poitout V; Robertson RP Diabetes; 2001 Nov; 50(11):2481-6. PubMed ID: 11679425 [TBL] [Abstract][Full Text] [Related]
19. Experimental hypothalamic or genetic obesity in the non-insulin-dependent diabetic rat. Portha B; Goursot R; Giroix MH; Nicolaïdis S; Picon L Diabetologia; 1983 Jul; 25(1):51-5. PubMed ID: 6350084 [TBL] [Abstract][Full Text] [Related]
20. The messenger RNA profiles in liver, hypothalamus, white adipose tissue, and skeletal muscle of female Zucker diabetic fatty rats after topiramate treatment. Liang Y; She P; Wang X; Demarest K Metabolism; 2006 Oct; 55(10):1411-9. PubMed ID: 16979414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]